Despite challenges for approval and access, regenerative therapies for retinal diseases may not be far away from becoming ...

In this video from the American Academy of Dermatology Annual Meeting, Brian S. Kim, MD, MTR, discusses the expansion of ...

CHICAGO — Alcohol-related cirrhosis carries a twofold higher mortality risk than cirrhosis stemming from metabolic ...

The 5th Circuit Court of Appeals has temporarily restored a rule the FDA lifted in 2023 that requires mifepristone to be ...

The AI-assisted colonoscopy era was associated with a 47% reduction in interval colorectal cancer incidence and higher ...

Sharp differences in mortality rates and costs related to alcohol-associated hepatitis before and after the COVID-19 pandemic ...

Until biomarkers that can predict treatment response emerge, early and aggressive treatment is recommended in lupus nephritis ...

AI highlighted evidence-based research when asked about the safety of acetaminophen use during pregnancy, according to data ...

The FDA has approved the first proteolysis-targeting chimera for any oncologic indication. Vepdegestrant (Veppanu, Arvinas ...

Once-weekly semaglutide was tied to a reduction in heavy drinking days among adults with obesity and alcohol use disorder, ...

BillionToOne, a molecular diagnostics company, announced the launch of a noninvasive test for pregnancies with high fetal ...

In 2026, the biggest drivers of market trends in ophthalmology include rare diseases as well as gene therapies and AI, ...